Close

Form 8-K BLONDER TONGUE LABORATOR For: Nov 14

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. SPY
3. SPOT
4. GM
5. AMZN
6. SHW
7. MSCI
8. AAPL
9. NVDA


November 14, 2014 9:45 AM EST

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549



FORM 8-K
�
Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934



Date of Report (Date of earliest event reported): November 14, 2014
�
�
Blonder Tongue Laboratories, Inc.
(Exact Name of registrant as specified in its charter)
�
�
�
Delaware
(State or other jurisdiction of incorporation)
�
�
�
1-14120
(Commission File Number)
�
�
�
52-1611421
(I.R.S. Employer Identification No.)
�
�
One Jake Brown Road, Old Bridge, New Jersey��08857
(Address of principal executive offices)��(Zip Code)
�
�
�
Registrants telephone number, including area code:�� (732) 679-4000
�
�
Not Applicable
(Former name or former address, if changed since last report)

�
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
�
�
[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
�
�
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
�
�
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
�
�
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
�

�
�
�

Item 2.02.��Results of Operations and Financial Condition
�
On November 14, 2014, Blonder Tongue Laboratories, Inc. issued a press release announcing its��unaudited financial results for the third quarter ended September 30, 2014.��A copy of the press release is attached to this Report as Exhibit 99.1 and is incorporated herein by reference.��The information disclosed in this report, including Exhibit 99.1 hereto, is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934.
�
Item 9.01.��Financial Statements and Exhibits
�
(a)��
Not applicable
�
(b)��
Not applicable
�
(c)��
Not applicable
�
(d)��
The following exhibits are filed herewith:
�
Exhibit 99.1���������������������������Press Release dated November 14, 2014.
�
�
�
�

2

�
�
�

SIGNATURE
�
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
�
BLONDER TONGUE LABORATORIES, INC.



By:����������/s/ Eric Skolnik����������������������������������������������������������������
Eric Skolnik
Senior Vice President and Chief Financial Officer
�
Date: November 14, 2014



3


�
�
�





EXHIBIT INDEX


Exhibit No.
Description
� �
Exhibit 99.1
Press Release of Blonder Tongue Laboratories, Inc. dated November 14, 2014 regarding its unaudited financial results for the third quarter ended September 30, 2014.
�

�
�
�
4

EXHIBIT 99.1
�


�

�
�
FOR IMMEDIATE RELEASE:
�

Blonder Tongue Reports Third Quarter 2014 Results
Second Consecutive Quarter of Profitability

OLD BRIDGE, New JerseyNovember 14, 2014Blonder Tongue Laboratories, Inc. (NYSE MKT: BDR) announced its sales and results for the third quarter and nine months ended September 30, 2014.

Net sales increased $1,836,000, or 26.9%, to $8,659,000 in the third three months of 2014 from $6,823,000 in the third three months of 2013.��Net earnings for the third three months ended September 30, 2014 were $584,000 or $0.09 per share, compared to a net loss of $(688,000) or $(0.11) per share for the comparable period in 2013.

The increase in net sales is primarily attributed to an increase in sales of digital video headend products and analog video headend products offset by a decrease in sales of contract manufactured products.��Sales of digital video headend products were $4,508,000 and $2,901,000, sales of analog video headend products were $2,318,000 and $1,655,000 and sales of contract manufactured products were $82,000 and $772,000 in the third three months of 2014 and 2013, respectively.

For the nine month period ended September 30, net sales increased $2,377,000, or 11.5%, to $23,065,000 in 2014 from $20,688,000 in 2013.��Net loss for the nine months ended September 30, 2014 was $(230,000) or $(0.04) per share, compared to $(1,830,000) or $(0.29) per share for the comparable period in 2013.

The increase in net sales is primarily attributed to an increase in sales of digital video headend products and analog video headend products offset by a decrease in sales of contract manufactured products.��Sales of digital video headend products were $12,034,000 and $9,309,000, sales of analog video headend products were $5,979,000 and $4,250,000 and sales of contract manufactured products were $296,000 and $2,802,000 in the first nine months of 2014 and 2013, respectively.

Commenting on the third quarter 2014, Chairman and Chief Executive Officer James A. Luksch noted, Third quarter 2014 results, as with the second quarter, are a significant improvement over 2013.��Our solid gains in both sales and gross margins, are driven by our ability to develop new products which are serving specific customer needs.��Our price performance ratio relative to competition, is another driving factor.��Our digital product strategy remains on course with planned releases of new products scheduled through the rest of 2014 and thereafter.


Conference Call Reminder
Details of the live teleconference and webcast are as follows:
Date:�����������Friday, November 14, 2014
Time:�����������11:00 a.m. Eastern Time (10:00 a.m. CT, 8:00 a.m. PT)
Investor Dial-in (US & Canada Toll-Free):��877-407-8033
Live Webcast: http://www.investorcalendar.com/IC/CEPage.asp?ID=173409
�
�
�
The teleconference replay can be accessed until February 14, 2015, by dialing 877-660-6853 and using Conference ID # 13595449. The webcast link will be available under Investor Related Information�on the Blonder Tongue Investor Relations webpage.


About Blonder Tongue
Blonder Tongue Laboratories, Inc. together with R. L. Drake Holdings, LLC - its wholly owned subsidiary - offer customers more than 130 years of combined engineering and manufacturing excellence with solid histories of delivering reliable, quality products.��As a leader in the field of cable television communications, the Company provides system operators and integrators serving the cable, broadcast, satellite, IPTV, institutional and professional video markets with comprehensive solutions for the provision of content contribution, distribution and video delivery to homes and businesses.��The Company designs, manufactures, sells and supports an equipment portfolio of standard and high definition digital video solutions, as well as core analog video and high speed data solutions for distribution over coax, fiber and IP networks.��Additional information on the Company and its products can be found at www.blondertongue.com, and www.rldrake.com.
�
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The information set forth above includes forward-looking statements and accordingly, the cautionary statements contained in Blonder Tongues Annual Report and Form 10-K for the year ended December 31, 2013 (See Item 1: Business, Item 1A: Risk Factors, Item 3: Legal Proceedings and Item 7: Managements Discussion and Analysis of Financial Condition and Results of Operations), and other filings with the Securities and Exchange Commission are incorporated herein by reference.��The words believe, expect, anticipate, project, target, intend, plan, seek, estimate, endeavor, should, could, may and similar expressions are intended to identify forward-looking statements.��In addition, any statements that refer to projections for our future financial performance, our anticipated growth trends in our business and other characterizations of future events or circumstances are forward-looking statements.��Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect managements analysis only as of the date hereof. Blonder Tongue undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.��Blonder Tongues actual results may differ from the anticipated results or other expectations expressed in Blonder Tongues forward-looking statements.
�
�
Contacts
�
Eric Skolnik
Chief Financial Officer
(732) 679-4000
�
James A. Luksch
Chief Executive Officer
(732) 679-4000
�

�

�

�

�
�
�

�






Blonder Tongue Laboratories, Inc.
Consolidated Summary of Operating Results
(in thousands, except per share data)

����������������(unaudited)

�
Three months ended
Nine months ended
�
September 30,
September 30,
�
2014
2013
2014
2013
� � � � �
Net sales
$8,659
$6,823
$23,065
$20,688
Gross profit
3,486
2,273
8,718
7,213
Earnings (loss) from operations
653
(624)
(47)
(1,620)
Net earnings (loss)
$584
$(688)
$(230)
$(1,830)
Basic and diluted net earnings (loss) per share
$0.09
$(0.11)
$(0.04)
$(0.29)
Basic weighted average shares outstanding
6,226
6,216
6,220
6,216
Diluted weighted average shares outstanding
6,320
6,216
6,220
6,216
�
�
�


Consolidated Summary Balance Sheets
(in thousands)
�
����������������(unaudited)
�
�
September 30,
2014
December 31,
2013
� � �
Current assets
$13,242
$13,156
Property, plant, and equipment, net
3,879
3,710
Total assets
22,402
22,641
Current liabilities
7,284
3,657
Long-term liabilities
122
3,956
Stockholders equity
14,996
15,028
� � �
Total liabilities and stockholders equity
$22,402
$22,641




�



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings